252 related articles for article (PubMed ID: 27427224)
1. Statin use and kidney cancer outcomes: A propensity score analysis.
Nayan M; Finelli A; Jewett MAS; Juurlink DN; Austin PC; Kulkarni GS; Hamilton RJ
Urol Oncol; 2016 Nov; 34(11):487.e1-487.e6. PubMed ID: 27427224
[TBL] [Abstract][Full Text] [Related]
2. Diabetes and kidney cancer outcomes: a propensity score analysis.
Nayan M; Finelli A; Jewett MA; Juurlink DN; Austin PC; Kulkarni GS; Hamilton RJ
Endocrine; 2017 Feb; 55(2):470-477. PubMed ID: 27815768
[TBL] [Abstract][Full Text] [Related]
3. The association of statin therapy with clinicopathologic outcomes and survival among patients with localized renal cell carcinoma undergoing nephrectomy.
Viers BR; Houston Thompson R; Psutka SP; Lohse CM; Cheville JC; Leibovich BC; Tollefson MK; Boorjian SA
Urol Oncol; 2015 Sep; 33(9):388.e11-8. PubMed ID: 25700974
[TBL] [Abstract][Full Text] [Related]
4. Metformin Use and Kidney Cancer Outcomes in Patients With Diabetes: A Propensity Score Analysis.
Nayan M; Finelli A; Jewett MA; Juurlink DN; Austin PC; Kulkarni GS; Hamilton RJ
Clin Genitourin Cancer; 2017 Apr; 15(2):300-305. PubMed ID: 27424258
[TBL] [Abstract][Full Text] [Related]
5. Statin Use and Serum Lipid Levels Are Associated With Survival Outcomes After Surgery for Renal Cell Carcinoma.
Haddad AQ; Jiang L; Cadeddu JA; Lotan Y; Gahan JC; Hynan LS; Gupta N; Raj GV; Sagalowsky AI; Margulis V
Urology; 2015 Dec; 86(6):1146-52. PubMed ID: 26416007
[TBL] [Abstract][Full Text] [Related]
6. Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma.
Kaffenberger SD; Lin-Tsai O; Stratton KL; Morgan TM; Barocas DA; Chang SS; Cookson MS; Herrell SD; Smith JA; Clark PE
Urol Oncol; 2015 Jan; 33(1):21.e11-21.e17. PubMed ID: 25456998
[TBL] [Abstract][Full Text] [Related]
7. Statin utilization improves oncologic and survival outcomes in patients with dyslipidemia and surgically treated renal cell carcinoma.
Berquist SW; Lee HJ; Hamilton Z; Bagrodia A; Hassan AE; BeksaƧ AT; Dufour CA; Wang S; Mehrazin R; Patterson A; Derweesh IH
Minerva Urol Nefrol; 2017 Oct; 69(5):501-508. PubMed ID: 28376607
[TBL] [Abstract][Full Text] [Related]
8. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
[TBL] [Abstract][Full Text] [Related]
9. Statins and survival outcomes in patients with metastatic renal cell carcinoma.
McKay RR; Lin X; Albiges L; Fay AP; Kaymakcalan MD; Mickey SS; Ghoroghchian PP; Bhatt RS; Kaffenberger SD; Simantov R; Choueiri TK; Heng DY
Eur J Cancer; 2016 Jan; 52():155-62. PubMed ID: 26687834
[TBL] [Abstract][Full Text] [Related]
10. Preserving Renal Function through Partial Nephrectomy Depends on Tumor Complexity in T1b Renal Tumors.
Yoo S; You D; Jeong IG; Hong B; Hong JH; Kim CS; Ahn H; Song C
J Korean Med Sci; 2017 Mar; 32(3):495-501. PubMed ID: 28145654
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness of Initial Surgery vs Initial Systemic Therapy for Metastatic Kidney Cancer in the Targeted Therapy Era: Analysis of a Population-based Cohort.
Macleod LC; Odisho AY; Tykodi SS; Holt SK; Harper JD; Gore JL
Urology; 2018 Mar; 113():146-152. PubMed ID: 29174942
[TBL] [Abstract][Full Text] [Related]
12. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
[TBL] [Abstract][Full Text] [Related]
13. Effects of statin therapy on clinical outcomes after acute myocardial infarction in patients with advanced renal dysfunction: A propensity score-matched analysis.
Kim JS; Kim W; Park JY; Woo JS; Lee TW; Ihm CG; Kim YG; Moon JY; Lee SH; Jeong MH; Jeong KH;
PLoS One; 2017; 12(8):e0183059. PubMed ID: 28806769
[TBL] [Abstract][Full Text] [Related]
14. Comparative Effectiveness of Statin Therapy in Chronic Kidney Disease and Acute Myocardial Infarction: A Retrospective Cohort Study.
Smith DH; Johnson ES; Boudreau DM; Cassidy-Bushrow AE; Fortmann SP; Greenlee RT; Gurwitz JH; Magid DJ; McNeal CJ; Reynolds K; Steinhubl SR; Thorp M; Tom JO; Vupputuri S; VanWormer JJ; Weinstein J; Yang X; Go AS; Sidney S
Am J Med; 2015 Nov; 128(11):1252.e1-1252.e11. PubMed ID: 26169887
[TBL] [Abstract][Full Text] [Related]
15. Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis.
Mohanty A; Tate JP; Garcia-Tsao G
Gastroenterology; 2016 Feb; 150(2):430-40.e1. PubMed ID: 26484707
[TBL] [Abstract][Full Text] [Related]
16. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
[TBL] [Abstract][Full Text] [Related]
17. The association between statin medication and progression after surgery for localized renal cell carcinoma.
Hamilton RJ; Morilla D; Cabrera F; Leapman M; Chen LY; Bernstein M; Hakimi AA; Reuter VE; Russo P
J Urol; 2014 Apr; 191(4):914-9. PubMed ID: 24291547
[TBL] [Abstract][Full Text] [Related]
18. Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis.
Nayan M; Jalali S; Kapoor A; Finelli A; So A; Rendon R; Breau RH; Lavallee LT; Tanguay S; Heng D; Kawakami J; Basappa NS; Bjarnason G; Pouliot F; Hamilton RJ
Urol Oncol; 2019 Sep; 37(9):576.e11-576.e16. PubMed ID: 31285115
[TBL] [Abstract][Full Text] [Related]
19. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
O'Malley RL; Hayn MH; Brewer KA; Underwood W; Hellenthal NJ; Kim HL; Sorokin I; Schwaab T
World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189
[TBL] [Abstract][Full Text] [Related]
20. Assessment of survival of patients with metastatic clear cell renal cell carcinoma after radical cytoreductive nephrectomy versus no surgery: a seer analysis.
Xiao WJ; Zhu Y; Dai B; Zhang HL; Ye DW
Int Braz J Urol; 2015; 41(2):288-95. PubMed ID: 26005970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]